LMP2A survival and developmental signals are transmitted through Btk-dependent and Btk-independent pathways - PubMed (original) (raw)
. 2001 Dec 5;291(1):46-54.
doi: 10.1006/viro.2001.1187.
Affiliations
- PMID: 11878875
- DOI: 10.1006/viro.2001.1187
Free article
LMP2A survival and developmental signals are transmitted through Btk-dependent and Btk-independent pathways
M Merchant et al. Virology. 2001.
Free article
Abstract
The latent membrane protein 2A (LMP2A) of Epstein--Barr virus (EBV) has been implicated in controlling viral latency due to the ability of LMP2A to block B cell antigen receptor (BCR) signaling in vitro and to alter B cell development and enhance B cell survival in vivo. These LMP2A functions require interactions with the protein tyrosine kinases Syk and Lyn. However, a role for the Bruton's tyrosine kinase (Btk) has not been investigated for these LMP2A functions. To investigate whether Btk is important for LMP2A developmental and survival signals in vivo, LMP2A transgenic animals were mated to Btk deficient (Btk(-/-)) mice. Unlike LMP2A(+), Btk(+/+) transgenic littermate controls, LMP2A(+), Btk(-/-) animals do not generate immunoglobulin (Ig) receptorless B cells in the periphery and instead produce Ig(+) B cells similar to those in the Btk(-/-) mice. Interestingly, however, LMP2A(+), Btk(-/-) animals produce B cells at a vastly reduced level compared to Btk(-/-) littermates, indicating that LMP2A affects B cell development in the absence of Btk. In the RAG-1(-/-), Btk(-/-) double knockout background, LMP2A is still capable of enhancing the survival of Ig-receptorless B cells. Use of Btk phosphopeptide-specific antibodies reveals that Btk is constitutively phosphorylated in LMP2A-expressing cell lines. These data indicate that LMP2A initiates both Btk-dependent and Btk-independent pathways, resulting in altered B cell development and enhanced B cell survival.
Copyright 2001 Elsevier Science.
Similar articles
- The Epstein-Barr virus latent membrane protein 2A PY motif recruits WW domain-containing ubiquitin-protein ligases.
Ikeda M, Ikeda A, Longan LC, Longnecker R. Ikeda M, et al. Virology. 2000 Mar 1;268(1):178-91. doi: 10.1006/viro.1999.0166. Virology. 2000. PMID: 10683340 - Epstein-Barr virus (EBV) LMP2A mediates B-lymphocyte survival through constitutive activation of the Ras/PI3K/Akt pathway.
Portis T, Longnecker R. Portis T, et al. Oncogene. 2004 Nov 11;23(53):8619-28. doi: 10.1038/sj.onc.1207905. Oncogene. 2004. PMID: 15361852 - Epstein-Barr Virus Latent Membrane Protein 2A (LMP2A) enhances IL-10 production through the activation of Bruton's tyrosine kinase and STAT3.
Incrocci R, Barse L, Stone A, Vagvala S, Montesano M, Subramaniam V, Swanson-Mungerson M. Incrocci R, et al. Virology. 2017 Jan;500:96-102. doi: 10.1016/j.virol.2016.10.015. Epub 2016 Oct 25. Virology. 2017. PMID: 27792904 Free PMC article. - Epstein-Barr virus protein LMP2A regulates reactivation from latency by negatively regulating tyrosine kinases involved in sIg-mediated signal transduction.
Miller CL, Lee JH, Kieff E, Burkhardt AL, Bolen JB, Longnecker R. Miller CL, et al. Infect Agents Dis. 1994 Apr-Jun;3(2-3):128-36. Infect Agents Dis. 1994. PMID: 7812651 Review. - Btk function in B cell development and response.
Satterthwaite AB, Li Z, Witte ON. Satterthwaite AB, et al. Semin Immunol. 1998 Aug;10(4):309-16. doi: 10.1006/smim.1998.0123. Semin Immunol. 1998. PMID: 9695187 Review.
Cited by
- Rewiring of B cell receptor signaling by Epstein-Barr virus LMP2A.
Fish K, Comoglio F, Shaffer AL 3rd, Ji Y, Pan KT, Scheich S, Oellerich A, Doebele C, Ikeda M, Schaller SJ, Nguyen H, Muppidi J, Wright GW, Urlaub H, Serve H, Staudt LM, Longnecker R, Oellerich T. Fish K, et al. Proc Natl Acad Sci U S A. 2020 Oct 20;117(42):26318-26327. doi: 10.1073/pnas.2007946117. Epub 2020 Oct 5. Proc Natl Acad Sci U S A. 2020. PMID: 33020271 Free PMC article. - Dasatinib exacerbates splenomegaly of mice inoculated with Epstein-Barr virus-infected lymphoblastoid cell lines.
Kotaki R, Kawashima M, Yamamoto Y, Higuchi H, Nagashima E, Kurosaki N, Takamatsu M, Kikuti YY, Imadome KI, Nakamura N, Kotani A. Kotaki R, et al. Sci Rep. 2020 Mar 9;10(1):4355. doi: 10.1038/s41598-020-61300-y. Sci Rep. 2020. PMID: 32152351 Free PMC article. - Epstein-Barr virus in Burkitt's lymphoma: a role for latent membrane protein 2A.
Bieging KT, Swanson-Mungerson M, Amick AC, Longnecker R. Bieging KT, et al. Cell Cycle. 2010 Mar 1;9(5):901-8. doi: 10.4161/cc.9.5.10840. Epub 2010 Mar 3. Cell Cycle. 2010. PMID: 20160479 Free PMC article. - Calcium-dependent signalling in B-cell lymphomas.
Berditchevski F, Fennell E, Murray PG. Berditchevski F, et al. Oncogene. 2021 Nov;40(45):6321-6328. doi: 10.1038/s41388-021-02025-8. Epub 2021 Oct 8. Oncogene. 2021. PMID: 34625709 Free PMC article. Review. - Epstein-Barr virus latent membrane protein 2A exacerbates experimental autoimmune encephalomyelitis and enhances antigen presentation function.
Chang RA, Miller SD, Longnecker R. Chang RA, et al. Sci Rep. 2012;2:353. doi: 10.1038/srep00353. Epub 2012 Apr 3. Sci Rep. 2012. PMID: 22616025 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
- AI07476/AI/NIAID NIH HHS/United States
- CA09560/CA/NCI NIH HHS/United States
- CA62234/CA/NCI NIH HHS/United States
- CA73507/CA/NCI NIH HHS/United States
- DE13127/DE/NIDCR NIH HHS/United States
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Miscellaneous